The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expanded RAS and BRAF V600 testing as predictive biomarkers for single agent cetuximab in the randomized phase III CO.17 trial.
 
Jonathan M. Loree
Consulting or Advisory Role - Ipsen; Novartis; Taiho Pharmaceutical
 
Anthony Dowers
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Dan Edelstein
Employment - Sysmex
Travel, Accommodations, Expenses - Sysmex
 
Hannah Quinn
Employment - Sysmex
 
Derek J. Jonker
No Relationships to Disclose
 
Chris Karapetis
No Relationships to Disclose
 
Timothy Jay Price
Consulting or Advisory Role - Amgen; Merck Serono (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen
 
John Raymond Zalcberg
Honoraria - Amgen; Bayer; Merck Serono; pfizer; Roche; Specialised Therapeutics
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Pfizer; Roche; Specialised Therapeutics
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Shire (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Malcolm J. Moore
Honoraria - Celgene
 
Paul Michael Waring
No Relationships to Disclose
 
Hagen F. Kennecke
No Relationships to Disclose
 
Stanley R. Hamilton
Consulting or Advisory Role - Bristol-Myers Squibb; HalioDx; Loxo; Merck; Philips Electronics; Thermo Fisher Scientific
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Biocartis; EMD Serono; Genentech; Holy Stone Healthcare; Holy Stone Healthcare; Karyopharm Therapeutics; Merck; Navire; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)